Celldex Therapeutics (CLDX) Treasury Shares (2011 - 2019)
Celldex Therapeutics (CLDX) recorded quarterly Treasury Shares of $1110.0 in Q4 2019, down 68.75% quarter-over-quarter from $3552.0 in Q4 2018, and down 68.75% on a YoY basis from $3552.0 in Q4 2018.
Celldex Therapeutics (CLDX) Treasury Shares (2011 - 2019) Analysis & Trends
Celldex Therapeutics' Treasury Shares history runs 9 years deep, the most recent figure standing at $1110.0 for Q4 2019.
- In Q4 2019, Treasury Shares fell 68.75% year-over-year to $1110.0; the TTM figure through Dec 2019 stood at $1110.0 (down 68.75% YoY), while the FY2019 annual figure was $1110.0, down 68.75% from the prior year.
- Treasury Shares was $1110.0 for Q4 2019 at Celldex Therapeutics, down from $3552.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $50000.0 in Q4 2016 to a low of $1110.0 in Q4 2019.
- Historically, Treasury Shares has averaged $16121.4 across 5 years, with a median of $6445.0 in 2017.
- The sharpest annual moves came in 2015 and 2017: Treasury Shares surged 178.57% in 2015, then slumped 87.11% in 2017.
- A 5-year view of Treasury Shares shows it stood at $19500.0 in 2015, then surged by 156.41% to $50000.0 in 2016, then plunged by 87.11% to $6445.0 in 2017, then sank by 44.89% to $3552.0 in 2018, then plunged by 68.75% to $1110.0 in 2019.
- The last three Treasury Shares figures came in at $1110.0 (Q4 2019), $3552.0 (Q4 2018), and $6445.0 (Q4 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1,110.00 |
| Dec 31, 2019 | 1,110.00 |
| Dec 31, 2018 | 3,552.00 |
| Dec 31, 2018 | 3,552.00 |
| Dec 31, 2017 | 6,445.00 |
| Dec 31, 2017 | 6,445.00 |
| Dec 31, 2016 | 50,000.00 |
| Dec 31, 2016 | 50,000.00 |
| Dec 31, 2015 | 19,500.00 |
| Dec 31, 2015 | 19,500.00 |
| Dec 31, 2014 | 7,000.00 |
| Dec 31, 2014 | 7,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2012 | 6,000.00 |
| Dec 31, 2012 | 6,000.00 |
| Jun 30, 2012 | 12,000.00 |
| Jun 30, 2012 | 12,000.00 |
| Dec 31, 2011 | 6,000.00 |
| Dec 31, 2011 | 6,000.00 |